drugset / Trial / NCT01543685

Study of Indomethacin Capsules to Treat Pain Following Bunionectomy

NCT01543685 ↗

Phase 3 Completed 462 enrolled Iroko Pharmaceuticals, LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Indomethacin \[Test\] Capsules are safe and effective for the treatment of postoperative bunionectomy pain.

Timeline

Start
2012-02
Primary completion
2012-06
Completion
2012-07

Outcome

Met primary endpoint

registry Indomethacin 40 mg TID vs Placebo; p <0.001; Difference in Least Squares Mean 441.8 (95% CI 187.1 to 696.5); ANCOVA NCT01543685 ↗

registry Indomethacin 40 mg BID vs Placebo; p = 0.046; Difference in Least Squares Mean 260.2 (95% CI 4.1 to 516.3); ANCOVA NCT01543685 ↗

registry Indomethacin 20 mg TID vs Placebo; p = 0.017; Difference in Least Squares Mean 312.7 (95% CI 56.6 to 568.9); ANCOVA NCT01543685 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg —
Subject Indomethacin Small molecule 20 mg —
Subject Indomethacin Small molecule 40 mg —

Indications

No indication recorded.